APA (7th ed.) Citation

J, O., JA, T., FJ, A., & A, O. (2022). Anticancer drugs tamoxifen and 4hydroxytamoxifen as effectors of phosphatidylethanolamine lipid polymorphism. Chemistry and physics of lipids, 248, 105239. https://doi.org/10.1016/j.chemphyslip.2022.105239

Chicago Style (17th ed.) Citation

J, Ortiz, Teruel JA, Aranda FJ, and Ortiz A. "Anticancer Drugs Tamoxifen and 4hydroxytamoxifen as Effectors of Phosphatidylethanolamine Lipid Polymorphism." Chemistry and Physics of Lipids 248 (2022): 105239. https://doi.org/10.1016/j.chemphyslip.2022.105239.

MLA (9th ed.) Citation

J, Ortiz, et al. "Anticancer Drugs Tamoxifen and 4hydroxytamoxifen as Effectors of Phosphatidylethanolamine Lipid Polymorphism." Chemistry and Physics of Lipids, vol. 248, 2022, p. 105239, https://doi.org/10.1016/j.chemphyslip.2022.105239.